{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:32:14Z","timestamp":1782729134555,"version":"3.54.5"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","award":["1320-PG"],"award-info":[{"award-number":["1320-PG"]}],"id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"and the Ministry of Business, Innovation, and Employment","award":["RTVU1503"],"award-info":[{"award-number":["RTVU1503"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0216113","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T13:35:32Z","timestamp":1557408932000},"page":"e0216113","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clozapine administration enhanced functional recovery after cuprizone demyelination"],"prefix":"10.1371","volume":"14","author":[{"given":"Nikki","family":"Templeton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn","family":"Kivell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"McCaughey-Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwen","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-7281","authenticated-orcid":true,"given":"Anne Camille","family":"La Flamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"issue":"16 Suppl","key":"ref1","first-page":"s294","article-title":"Multiple sclerosis update","volume":"19","author":"CE Markowitz","year":"2013","journal-title":"Am J Manag Care"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2007-1019124","article-title":"The immunology of multiple sclerosis","volume":"28","author":"A Bar-Or","year":"2008","journal-title":"Semin Neurol"},{"key":"ref3","article-title":"New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis","author":"C English","year":"2015","journal-title":"Clin Ther"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"H Lassmann","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","article-title":"Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia","volume":"52","author":"S Kapur","year":"2001","journal-title":"Annu Rev Med"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.9758\/cpn.2013.11.3.144","article-title":"Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures","volume":"11","author":"MM Al-Amin","year":"2013","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.pnpbp.2004.05.047","article-title":"Th1, Th2 and Th3 cytokine alteration in schizophrenia","volume":"28","author":"YK Kim","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0920-9964(00)00094-3","article-title":"Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor","volume":"54","author":"M Maes","year":"2002","journal-title":"Schizophr Res"},{"issue":"1","key":"ref9","article-title":"Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis","volume":"3","author":"LK Green","year":"2017","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"e104430","DOI":"10.1371\/journal.pone.0104430","article-title":"Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis","volume":"9","author":"D O'Sullivan","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yhbeh.2009.06.004","article-title":"Remyelination\u2014An effective means of neuroprotection","volume":"57","author":"CC Bruce","year":"2010","journal-title":"Hormones and Behavior"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn917","article-title":"Why does remyelination fail in multiple sclerosis?","volume":"3","author":"RJM Franklin","year":"2002","journal-title":"Nature Reviews Neuroscience"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2008.070850","article-title":"Cortical Demyelination Is Prominent in the Murine Cuprizone Model and Is Strain-Dependent","volume":"172","author":"T Skripuletz","year":"2008","journal-title":"American Journal of Pathology"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12311-009-0099-3","article-title":"Cuprizone Treatment Induces Distinct Demyelination, Astrocytosis, and Microglia Cell Invasion or Proliferation in the Mouse Cerebellum","volume":"8","author":"A Groebe","year":"2009","journal-title":"Cerebellum"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/glia.23272","article-title":"Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination","volume":"66","author":"S Kim","year":"2018","journal-title":"Glia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nbd.2013.07.003","article-title":"Cuprizone short-term exposure: Astrocytic IL-6 activation and behavioral changes relevant to psychosis","volume":"59","author":"T Tezuka","year":"2013","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-510X(99)00181-1","article-title":"The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro","volume":"168","author":"W Cammer","year":"1999","journal-title":"Journal of the neurological sciences"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System","volume":"11","author":"GK Matsushima","year":"2001","journal-title":"Brain Pathology"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2012.04.006","article-title":"Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination","volume":"138","author":"Y Zhang","year":"2012","journal-title":"Schizophrenia Research"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuro.2010.05.008","article-title":"Cuprizone neurotoxicity, copper deficiency and neurodegeneration","volume":"31","author":"F Benetti","year":"2010","journal-title":"NeuroToxicology"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/mcne.2000.0883","article-title":"Interferon-\u03b3 Protects against Cuprizone-Induced Demyelination","volume":"16","author":"X Gao","year":"2000","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/glia.1107","article-title":"Immune function of astrocytes","volume":"36","author":"Y Dong","year":"2001","journal-title":"Glia"},{"issue":"17","key":"ref23","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1007\/s00018-008-8059-5","article-title":"Astrocytes in multiple sclerosis: a product of their environment","volume":"65","author":"A Nair","year":"2008","journal-title":"Cellular and molecular life sciences: CMLS"},{"issue":"Part B","key":"ref24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuropharm.2015.10.010","article-title":"Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis","volume":"110","author":"KA Chamberlain","year":"2016","journal-title":"Neuropharmacology"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.pnpbp.2006.05.006","article-title":"Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells","volume":"30","author":"Y Hou","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref26","article-title":"Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation","author":"X Hu","year":"2011","journal-title":"J Neuroimmune Pharmacol"},{"issue":"23","key":"ref27","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.febslet.2011.03.047","article-title":"Astrocytes in the tempest of multiple sclerosis","volume":"585","author":"D Miljkovi\u0107","year":"2011","journal-title":"FEBS letters"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/brain\/aws262","article-title":"Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination","volume":"136","author":"T Skripuletz","year":"2013","journal-title":"Brain"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00406-013-0414-3","article-title":"Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone","volume":"264","author":"H Xu","year":"2014","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"e42746","DOI":"10.1371\/journal.pone.0042746","article-title":"Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation","volume":"7","author":"F Mei","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12974-017-0842-5","article-title":"Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses","volume":"14","author":"P Zareie","year":"2017","journal-title":"J Neuroinflammation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0216113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:37:24Z","timestamp":1588966644000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0216113"}},"subtitle":[],"editor":[{"given":"Fernando","family":"de Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0216113","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,9]]}}}